Published in Gene Therapy Weekly, January 12th, 2012
"We predicted that this persistent STAT3 signaling affects a wide variety of cellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.